Bluebird bio, Inc.
BLUE
Classificação em ações
#15668
bluebird bio, Inc. is a biotechnology firm that concentrates on the discovery,... bluebird bio, Inc. is a biotechnology firm that concentrates on the discovery, development, and commercialization of innovative gene therapies. These pioneering treatments are aimed at debilitating genetic conditions. Among its leading investigational therapies for severe inherited diseases are betibeglogene autotemcel (beti-cel), intended for patients with transfusion-dependent beta-thalassemia; lovotibeglogene autotemcel (lovo-cel), which targets sickle cell disease (SCD); and elivaldogene autotemcel (eli-cel), developed to address cerebral adrenoleukodystrophy. The company's robust clinical trial program is actively evaluating the safety and efficacy of these treatments. Specifically, lovo-cel's impact on SCD patients is being assessed in studies HGB-205, HGB-206, and HGB-210. Concurrently, beti-cel is under investigation for beta-thalassemia in trials HGB-204, HGB-205, HGB-207, and HGB-212. Furthermore, bluebird bio maintains strategic collaborations and licensing arrangements with entities such as Orchard Therapeutics Limited, Forty Seven, Inc., and Magenta Therapeutics, Inc. The company, which began its operations in 1992, was formerly known as Genetix Pharmaceuticals, Inc., and rebranded as bluebird bio, Inc. in September 2010. Its principal office is located in Cambridge, Massachusetts.
Preço da ação
$4.97
Última sincronização: 2025-06-02
Valor de mercado
$318.62M
Variação (1 dia)
0.00%
Variação (1 ano)
-38.03%
País
US
Negociar Bluebird bio, Inc. (BLUE)
Categoria
Healthcare
Histórico de desdobramentos de ações de Bluebird bio, Inc. (BLUE)
As ações Bluebird bio, Inc. (símbolo: BLUE) passaram por um total de 0 desdobramentos.
O desdobramento mais recente ocorreu em Oct 21, 2026.
Uma ação BLUE comprada antes de Oct 21, 2026 equivaleria hoje a 0 ações BLUE.
O desdobramento mais recente ocorreu em Oct 21, 2026.
Uma ação BLUE comprada antes de Oct 21, 2026 equivaleria hoje a 0 ações BLUE.
Lista de desdobramentos de ações
| Ano | Desdobramento | Multiplicador | Multiplicador cumulativo |
|---|---|---|---|
| Não há dados suficientes para as datas fornecidas. | |||
Desdobramentos de ações de empresas semelhantes ou concorrentes
| Empresa | Número de desdobramentos de ações | Multiplicador cumulativo | País |
|---|---|---|---|
| 1 | x2 |
US
|
|
| 0 | - |
US
|
|
| 1 | x3 |
AU
|
|
| 0 | - |
CH
|
|
| 0 | - |
NL
|
